Stay updated on Cariprazine in Bipolar I Relapse Prevention Clinical Trial
Sign up to get notified when there's something new on the Cariprazine in Bipolar I Relapse Prevention Clinical Trial page.

Latest updates to the Cariprazine in Bipolar I Relapse Prevention Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page history now shows a new Revision: v3.3.4 and the previous Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe page history shows an administrative update with Revision: v3.3.3 added and the HHS Vulnerability Disclosure link plus Revision: v3.3.2 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check59 days agoChange DetectedThe Record History page shows a new revision entry Revision: v3.3.2 and removes the previous Revision: v3.2.0, reflecting a site maintenance update to version history. This update affects the history metadata and does not alter the study data or content.SummaryDifference0.1%

- Check66 days agoChange DetectedThe government funding/operating status banner at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check80 days agoChange DetectedThe screenshots show a minor UI/layout update on the Record History page without changes to the study data or version contents. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check109 days agoChange DetectedSummary: The page now displays a funding-status notice and announces a major version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference11%

Stay in the know with updates to Cariprazine in Bipolar I Relapse Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cariprazine in Bipolar I Relapse Prevention Clinical Trial page.